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Background: Asthma is a frequent chronic respiratory disease in both children and adults. However, few data on
asthma prevalence are available in Portugal. The Portuguese National Asthma Survey is the first nationwide study
that uses standardized methods. We aimed to estimate the prevalence of current asthma in the Portuguese
population and to assess the association between ‘Current asthma’ and comorbidities such as upper airways
disease.
Methods: A cross-sectional, population-based, telephone interview survey including all municipalities of Portugal
was undertaken. Participants were randomly selected to answer a questionnaire based on the Portuguese version
of the GA2LEN survey. ‘Current asthma’ was defined as self-reported lifetime asthma and at least one of 3
symptoms in the last 12 months: wheezing, waking with breathlessness or having an asthma attack.
Results: Data were obtained for 6 003 respondents, with mean age of 38.9 (95%CI 38.2-39.6) years and 57.3%
females. In the Portuguese population, the prevalence of ‘Current asthma’ was 6.8% (95%CI 6.0-7.7) and of ‘Lifetime
asthma’ was 10.5% (95%CI 9.5-11.6) Using GA2LEN definition for asthma, our prevalence estimate was 7.8% (95%CI
7.0-8.8). Rhinitis had a strong association with asthma (Adjusted OR 3.87, 95%CI 2.90-5.18) and the association
between upper airway diseases and asthma was stronger in patients with both rhinitis and sinusitis (Adjusted OR
13.93, 95%CI 6.60-29.44).
Conclusions: Current asthma affects 695 000 Portuguese, with a prevalence of 6.8%. People who reported both
rhinitis and sinusitis had the highest risk of having asthma.
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Asthma is a chronic inflammatory disease of the airways
associated with episodes of wheezing, chest tightness,
shortness of breath and cough especially at night [1]. Epi-
demiological studies at a population level are crucial for
the assessment of population needs related to chronic re-
spiratory diseases, the baseline to define health policies
[2]. However few data on asthma prevalence are available
in Portugal and, as most of the studies use non-
standardized methods, prevalence estimates are difficult
to compare. Standardized methodology on asthma* Correspondence: jfonseca@med.up.pt
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reproduction in any medium, provided the orsymptoms prevalence is limited for ages between 20–
44 years old in European Community Respiratory Health
Survey (ECRHS) [3] and 6–7 and 13–14 years old in Inter-
national Study of Asthma and Allergies in Childhood
(ISAAC) [4]. In Portugal, both surveys were conducted in
a small number of cities [5,6]. Recently, the EU-funded
Global Allergy and Asthma European Network (GA2LEN)
is conducting a large survey on the prevalence of airway
diseases, built on methods used in earlier studies (mainly
ECRHS), however only one Portuguese city was included
[7]. The majority of the asthma studies in Portugal were
done on school-attending children and teenagers from
selected cities or regions [8-15]. For adults, the asthma
prevalence studies, published so far were done on military
service conscripts[16], in primary care units [17,18], using
postal questionnaires [19,20] or using postal questionnaireal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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survey conducted by the Observatório Nacional de Saúde
(ONSA) [22] in 2004 only included adults and asthma was
addressed only in a single question among many other
regarding chronic diseases. The Portuguese National
Health Survey of 2005/2006 [23] included participants
from all age groups, but the focus of the study were
chronic diseases in general and not asthma. Thus, none of
the published studies on asthma could give us truly
generalizable prevalence estimates for the Portuguese
population.
In 2010, we conducted the first Portuguese National
Asthma Survey - Inquérito Nacional sobre Asma (INAsma),
in collaboration with Sociedade Portuguesa de Alergologia e
Imunologia Clínica and Sociedade Portuguesa de Pneumo-
logia, by appointment of the Portuguese Health Directorate.
It comprised two phases. In the first phase, the aim was to
estimate the prevalence of current asthma and in the sec-
ond phase, the proportion of asthmatic patients with con-
trolled disease.
In this article we describe the first phase of INAsma
aiming to estimate the prevalence of current asthma in
the Portuguese population and to assess the association




This prevalence study was a cross-sectional, population-
based, nationwide telephone interview survey including
all municipalities of Portugal.
The study was approved by a Hospital Ethics Commit-
tee (Comissão de Ética do Hospital de São João, Porto).
All participants gave oral informed consent and were
informed that they could abandon the study whenever
they pleased, without any implication for their health-
care. Data confidentiality was guaranteed by storing per-
sonal information separately from the study data.
We followed the STROBE statement guidelines for
reporting observational studies [24].
Setting
Portugal is a country situated on the Iberian Peninsula,
in south-western Europe. It has seven regions including
the islands and 308 municipalities (NUTS II). The esti-
mated population in 2011 national census was 10 555
853 inhabitants. Most of the urban population is located
in littoral regions of the country, which are more indus-
trialized than interior regions.
Sample size
The sample size calculation was based in confidence inter-
vals for proportions. As so, for a prevalence of 6% [25]
and for the narrow error margin of 0.015, a sample of1067 individuals would be enough. However, the sample
size of this study was calculated considering the two
phases of the research project. In the first phase, we aimed
to estimate current asthma prevalence in the Portuguese
population. In the second phase we aimed to estimate the
proportion of asthma patients that have their disease con-
trolled. Thus, in phase 2 of the project, to estimate the
proportion of controlled asthma patients with a margin of
error of 3% and a 95% confidence level, assuming a pro-
portion of 20% of uncontrolled asthma patients in the
population, we needed a sample of at least 554 asthma
patients identified in the first phase of the project. Assum-
ing a loss of patients’ follow-up of 20%, we needed to re-
cruit at least 665 asthma patients during the first phase.
Within these premises, and assuming a prevalence of 6%
in the Portuguese population [25] and a margin of error of
0.65% we needed a sample of at least 6000 persons from
the general Portuguese population willing to participate in
the first phase of the project.
Participants
The target population was the Portuguese general popu-
lation and the available population included all indivi-
duals living in Portugal, in households with a landline
telephone (sampling frame). To obtain a representative
sample of the population, a stratified cluster sampling
design was used.
First, all municipalities were used as natural strata; in
each municipality a sample of households with landline
telephone numbers was selected with a probability pro-
portional to municipality population as estimated in the
2001 National Census. The target number of households
was set at 6 103. The sample of households was derived
from the directory listed in residential White Pages from
2010. To draw a sample of telephone numbers in a mu-
nicipality a list of all telephone numbers in that munici-
pality was compiled. From the whole list of each
municipality, a sample of household’s telephone num-
bers was randomly selected. Because part of the selected
telephone numbers are from companies or are not allo-
cated, 4 lists were randomly selected for each municipal-
ity, in order to allow for substitution of non-residential
telephone numbers. A total of 24 412 telephone num-
bers were retrieved.
Next, and after the selection and identification of a resi-
dential number, one participant was randomly selected in
each household. After identification of all the residents in
the household, the selected participant in each household
was the last person having his/her birthday. When the
selected individual was younger than 15 years old the re-
spondent was the usual caregiver. Individuals were
excluded if they did not understand spoken Portuguese or
had cognitive or physical conditions that could hamper the
interview. In the final 20% of the sample, an oversampling
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rect the common overrepresentation of participants from
the female sex and older age groups observed on an interim
analysis.
Instruments and data collection
The main instrument for data collection was the Portu-
guese version of the 21-item questionnaire used in the
GA2LEN survey. This questionnaire includes the ECHRS
questions on asthma symptoms [6,26]. A few additional
questions were added, mostly regarding socio-educational
variables and use of healthcare resources.
A private company administered the questionnaire
through Computer Assisted Telephone Interviews (CATI)
performed by trained and experienced interviewers. Inter-
views were conducted between March and May of 2010,
mostly between 17:00–22:00 h in weekdays and 11:00–
22:00 h in weekends and holidays. Each telephone number
was not abandoned before a minimum of ten attempts in
different occasions. The interviews had a mean duration
of 15 minutes.
To minimize other potential biases in data collection,
several quality assurance measures were followed: inter-
viewers were selected based on their previous experience
on health-related data collection; each question was dis-
cussed in training sessions held between researchers and
all interviewers; a research assistant was present in the
setup, training and daily work of the interviewers, motiv-
ating and checking the compliance with the standardized
operational procedures; data validity was periodically
verified soon after being collected and custom statistic
algorithms were used to detect extreme, illogical and
missing values; the clarity of the questionnaire and its
telephonic administration was assessed in a pilot study
with 25 individuals before starting the data collection.
Variables
The primary outcome, common co-morbidities and con-
founders were defined as follows:
Current asthma: positive answer to the question “Have
you ever had asthma?” and at least one of 3 symptoms
in the last 12 months: wheezing, waking with
breathlessness or having an asthma attack.
Lifetime asthma: positive answer to the question “Have
you ever had asthma?”
Diagnosed asthma: positive answer to the questions
“Have you ever had asthma?” and “Are you taking any
medication for asthma?”
Rhinitis: positive answer to the question “Do you have
any nasal allergies, including hay fever?” Further
classification of rhinitis in intermittent, persistent, mild
and moderate/severe was done according to ARIA
using GA2LEN survey questions [27].Sinusitis: positive answer to questions “Have you been
diagnosed as having chronic sinusitis by a doctor?” and
“Have you felt sinus pressure, pain around the eyes or
nose, for more than 12 weeks in last 12 months?”
Chronic bronchitis: positive answer to questions “Did
you have phlegm when coughing for at least 3 months
in the last year?” and smoked more than 10 Packs-year
and be at least 40 years old.
Eczema/atopic dermatitis: Positive answer to “Have you
ever had eczema or skin allergy?”
Drug allergy: Positive answer to “Have you been
diagnosed as having drug allergy by a doctor?”
Food allergy: Positive answer to “Have you been
diagnosed as having food allergy by a doctor?”
Wheeze: Positive answer to “Did you have wheezing or
whistling in your chest in the last 12 months?”
Asthma attack: Positive answer to “Did you have an
asthma attack in the last 12 months?”
Smokers reported smoking at least one cigarette every
day for one year; Ex-smokers reported having quit
smoking for more than one month; Non-smokers
reported neither smoking nor ex-smoking. Packs-year is
the number of cigarettes smoked per day / 20 * number
of years smoking.
Environmental Tobacco Smoke: Positive answer to
“Does anyone smokes inside your home?”
Heart disease: Positive answer to “Have you a heart
condition?”
Statistical analysis
The estimates from the sample were weighted so they
could be generalized to the target population. A two-stage
stratified sampling design was implemented using the
complex sampling module of IBM SPSS Statistics version
19 (2010 SPSS, Inc. an IBM Company). First, a simple ran-
dom sampling without replacement was used for selecting
a random sample of households with landline telephone
within each stratum (municipality). Second, within each
selected household, one eligible household resident was
randomly selected using simple random sampling without
replacement. Two types of weights were used: first,
weights were used to adjust for the sampling design taking
into account the probability of selection of each subject
and second, post-stratification weights were used to adjust
for the true sex and age distribution of the target popula-
tion (weights took into account sex and 5-year age strata
in each sampling stratum), thus partially correcting for
nonresponse and noncoverage bias.
Categorical variables were described with absolute fre-
quencies, proportions and 95% Confidence Interval (95%
CI). Comparisons of proportions were tested with Pear-
son Chi-Square for complex samples. A p-value of <0.05
was considered as statistically significant. Univariate ana-
lysis was used to assess associations between ‘Current
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non-respiratory allergic disease. In order to have a more
thorough understanding of the factors affecting its distri-
bution and risk, analysis of factors associated with
‘Current asthma’ were performed using univariate and
multivariate weighted logistic regression modelling. In the
multivariate logistic regression models, the dependent
variable was presence of ‘Current asthma’. Model
goodness-of-fit was assessed by the Hosmer-Lemeshow
test [28]. Discriminative/predictive power of the model
was evaluated by ROC curve analysis. Results are pre-
sented as odds ratios (OR) for each category as compared
with a predefined reference category and their respective
95% Confidence Intervals (95%CI). For the initial model
all the covariates with p-value of <0.25 were included. The
final multiple logistic regression model included the inde-
pendent variables age, education level, Environmental
Tobacco Smoke (ETS), rhinitis plus sinusitis, rhinitis with-
out sinusitis, sinusitis without rhinitis, eczema, drug al-
lergy and food allergy.
Statistical analyses were performed using IBM SPSS
Statistics version 19 (2010 SPSS, Inc. an IBM Company).
Results
Participants
Of 17 698 contacts, 6 003 subjects completed the inter-
view (Figure 1). The sample response rate was 40%; the
corrected response rate was 50%. The respondent was
the usual caregiver in 76.7% of the participants younger
than 15 years old. Participants’ characteristics are sum-
marized in Table 1. There were no missing data for the
variables that comprised the definition of ‘Current
asthma’.
Prevalence of asthma
The prevalence of ‘Diagnosed asthma’ was 5.0% (95%CI
4.2-5.8) and the ‘Lifetime asthma’ prevalence was 10.5%
(95%CI 9.5-11.6). In those with ‘Lifetime asthma’, 72.8%
had their first asthma attack before 18 years old, 25.5%
between 18 and 64 years old and 1.7% after 65 years old.
Current asthma
The prevalence of ‘Current asthma’ was 6.8% (95%CI
6.0-7.7). Using GA2LEN definition for asthma [7], our
prevalence estimate was 7.8% (95%CI 7.0-8.8).
‘Current asthma’ prevalence was similar in men and
women and in all age groups (Table 2). The prevalence
of asthma was similar in all body mass index (BMI)
groups, with tendency to be higher in obese people: 7.7%
(95%CI 2.2-23.3) in underweight group; 5.7% (95%CI
4.3-7.4) in normal weight; 6.4% (95%CI 5.1-8.1) in over-
weight and 8.7% (95%CI 6.5-11.4) in obese. There was
no association between being overweight or obese and‘Current asthma’ (Crude OR 1.13, 95%CI 0.78-1.64 and
1.54, 95%CI 1.01-2.34, respectively).
Asthma was more frequent in people who did not
smoke or smoked less than 10 packs-year (7.1%, 95%CI
6.2-8.2) than in those who smoked more than 10 packs-
year (5.2%, 95%CI 3.9-6.8; p = 0.042). Those who smoke
more have lower risk of asthma (Crude OR 0.71, 95%CI
0.51-0.99). This tendency was significant after adjust-
ments of unit packs-years for gender, age, BMI, educa-
tion level and for ETS (data not shown).
In the multiple logistic regression, the risk of ‘Current
asthma’ was assessed for age, education level, ETS, rhin-
itis with sinusitis, rhinitis without sinusitis, sinusitis
without rhinitis, eczema, drug allergy and food allergy
(Adjusted OR, Table 2). The Hosmer-Lemeshow statistic
revealed good fitting (p = 0.259) and the model’s predict-
ive power was acceptable (AUC = 0.74, 95%CI 0.71-
0.76).
Comorbidities
Of the subjects with ‘Current asthma’, 5.7% (95%CI 3.8-
8.5) also have chronic bronchitis (Table 3). More than
half of the subjects with ‘Current asthma’ also had rhin-
itis (52.3%, 95%CI 45.8-58.6), of which most were classi-
fied as intermittent moderate/severe (29.9%, 95%CI 24.4-
36.0) (Table 3). Rhinitis and Sinusitis alone had a strong
association with asthma (Crude OR 3.67, 95%CI 2.79-
4.82 and 1.33, 95%CI 0.47-3.76, respectively). Associ-
ation between upper airway diseases and asthma was
stronger in patients with both rhinitis and sinusitis
(Crude OR 9.34, 95%CI 4.75-18.35 and Adjusted OR
13.93, 95%CI 6.60-29.44, Table 2).
Subgroup analysis
To exclude possible confounding of asthma related
symptoms with symptoms from self-reported heart dis-
ease, heavy smoking habits (smoking more than 10
packs-year) and chronic bronchitis a subgroups analysis
was performed. Chronic bronchitis was the condition to
have less impact on prevalence of ‘Current asthma’,
whereas self-reported heart disease was the condition
with most impact (Figure 2). However, only in the older
adults subgroup the participants without self-reported
heart disease had a significantly lower prevalence of
current asthma (older adults without heart disease 4.9%,
95%CI 3.9-6.2; all older adults 8.0%, 95%CI 6.7-9.5).
Prevalence of symptoms
The most common respiratory symptom in the group
with ‘Current asthma’ was wheeze (89%, 95%CI 85.8-
91.6), followed by nocturnal symptoms (75.8%, 95%CI
70.8-80.2) (Table 4). Of those who reported ‘Wheeze’
and ‘Wheeze with breathlessness’ (Positive answer to
wheeze and “Did you have breathlessness when the
Sample of households
n=17 698














No wheezing, waking with 
breathlessnessss nor attack of 
asthma in last 12 months n=280
Figure 1 Participants flowchart. From the 17 698 households contacts, 6 003 participants were included in the study; 658 classified as having
‘Lifetime asthma’ and 450 as having ‘Current asthma’.
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(Positive answer to wheeze and “Did you have wheezing
without a could?”), 42.2% (95%CI 36.7-47.8) denied hav-
ing asthma.Healthcare resources
About 243 000 (2.4%, 95%CI 1.9-2.9) Portuguese were
hospitalized at least once in their lifetime because of
asthma. In Portuguese subjects with ‘Current asthma’,
25.6% were hospitalized because of their asthma
(Table 5). Current use of asthma medication (inhaled,
nebulized and/or oral medication) was reported by
60.1% of Portuguese subjects with ‘Current asthma’,
35.2% used inhaled controller medications and 21.6%
takes reliever medications only (Table 5).Discussion
In the present study the estimated prevalence of ‘Current
asthma’ in the Portuguese population was 6.8%. This study
also showed a strong association of asthma with rhinitis
and sinusitis, in agreement with the known risk of the
chronic disease of upper airways for asthma [27].
A limitation of the method used is the increasing pre-
ference for mobile phones over residential telephones.
However, the use of mobile phone does not allow strati-
fication by geographical region; reduces control over the
sampling method and has a lower response rate [29].
This study has the intrinsic limitations of a telephone
survey on asthma; such as the impossibility to determine
causality factors without risking biased inferences. Other
limitations are is the fact that the only data available by
the time of the data collection was the National Census
Table 1 Socio-demographic characteristics of the participants by ‘Current asthma’ status
Current asthma
Total (n = 6 003) Yes (n = 450) No (n = 5 553)
Municipality
Urban 4593 (76.5) 337 (74.9) 4256 (76.6)
Rural 1410 (23.5) 113 (25.1) 1297 (23.4)
Female, n (%) 3438 (57.3) 282 (62.7) 3156 (56.8)
Age groups, n (%)
<18 years old 716 (11.9) 56 (12.4) 660 (11.9)
18-65 years old 3104 (51.7) 211 (46.9) 2893 (52.1)
>65 years old 2178 (36.3) 183 (40.7) 1995 (36.0)
BMI†, n(%)
Underweight (<18) 253 ( 5.1) 18 ( 4.9) 235 ( 5.1)
Normal weight (18–25) 2179 (43.9) 140 (38.4) 2039 (44.3)
Overweight (25–30) 1825 (36.7) 128 (35.1) 1697 (36.9)
Obese (>30) 710 (14.3) 79 (21.6) 631 (13.7)
Education level{, n(%)
<9 years 3907 (65.5) 312 (69.6) 3595 (65.1)
9-12 years 1175 (19.7) 85 (19.0) 1090 (19.7)
>12 years 732 (12.3) 40 (8.9) 692 (12.5)
SES††, n(%)
Low 1289 (22.0) 111 (25.2) 1169 (21.7)
Medium 4137 (71.1) 1169 (21.7) 3831 (71.2)
High 405 ( 7.0) 23 ( 5.2) 382 ( 7.1)
Smoking status, n(%)
Non-smoker 4291 (71.5) 333 (74.0) 3958 (71.3)
Ex-smoker 971 (16.2) 71 (15.8) 900 (16.2)
Current smoker 741 (12.3) 46 (10.2) 695 (12.5)
Unit Packs-year, n(%)
≤10 Packs-year 4799 (79.9) 368 (82.3) 4431 (80.5)
>10 Packs-year 1150 (19.2) 79 (17.7) 1071 (19.5)
ETS{{, n(%)
No 4843 (80.7) 347 (77.1) 4496 (81.0)
Yes 1160 (19.3) 103 (22.9) 1057 (19.0)
†Body Mass Index. {A total of 153 (2.5%) children were pre-schoolers (not shown). ††Socioeconomic Status was categorized in high (A social class), medium (B and
C social classes) and low (D social class) based on occupation and school education of the person who contributes more for the household income.
{{Environmental Tobacco Smoke.
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could influence the sampling size; and the relatively low
response rate, still was among the highest obtained in
Portuguese nationwide telephone surveys [30,31]. In
other countries the asthma prevalence and outcomes are
different between ethnicities. It would be interesting to
compare the prevalence of asthma in the people with
different ethnic backgrounds in the Portuguese popula-
tion. However, in Portugal in what concerns ethnicity,
serious limitations on data collection are imposed and
no official data are available.Bias and confounding are limitations of all epidemio-
logical studies. To address this, we took into account pos-
sible information and selection bias and adjusted for
conditions with similar symptoms. Chronic Obstructive
Pulmonary Disease (COPD) can be difficult to differenti-
ate from asthma in surveys [32], especially when the pro-
portion of elders with respiratory symptoms is high and is
associated with asthma, as we have observed. Neverthe-
less, we believe misclassification of COPD patients had a
limited effect on our prevalence estimates. The analysis of
the participants without ‘Chronic bronchitis’ (phlegm
Table 2 Prevalence of ‘Current asthma’ and logistic regression models with crude and adjusted Odds Ratio (OR)
Current asthma % (95%CI) Crude OR (95%CI) Adjusted OR (95% CI)}
All Portuguese Population 6.8 ( 6.0- 7.7)
NUTS II
North 6.7 ( 5.5- 8.2) 1.00 (Ref)
Centre 6.2 ( 4.6- 8.3) 0.92 (0.63-1.35)
Lisbon 6.8 ( 5.4- 8.6) 1.01 (0.72-1.42)
Alentejo/Algarve 7.9 ( 5.4-11.3) 1.18 (0.75-1.87)
Madeira/Azores 6.6 ( 3.9-10.9) 0.98 (0.55-1.77)
Municipality
Urban 6.5 ( 5.6- 7.4) 1.00 (Ref)
Rural 7.7 ( 5.9-10.1) 1.22 (0.87-1.69)
Gender
Female 7.2 ( 6.0- 8.5) 1.00 (Ref)
Male 6.3 ( 5.2- 7.6) 0.87 (0.66-1.14)
Age groups
<18 years old 7.2 ( 5.4- 9.5) 1.00 (Ref) 1.00 (Ref)
18-65 years old 6.3 ( 5.3- 7.5) 0.86 (0.61-1.23) 0.94 (0.63-1.40)
>65 years old 8.0 ( 6.7- 9.5) 1.11 (0.78-1.59)* 1.51 (1.01-2.27)}*
Education level†
<9 years 7.1 ( 6.1- 8.2) 1.00 (Ref) 1.00 (Ref)
9-12 years 7.4 ( 5.6- 9.7) 1.05 (0.75-1.47) 0.92 (0.64-1.32)
>12 years 4.5 ( 3.0- 6.6) 0.62 (0.40-0.96) 0.44 (0.28-0.70)}**
SES{
Low 6.9 ( 5.3- 8.9) 1.00 (Ref)
Medium 6.9 ( 5.9- 8.0) 1.00 (0.73-1.37)
High 6.3 ( 3.8-10.3) 0.91 (0.50-1.66)
Smoking status
Non-smoker 6.9 ( 6.0- 8.0) 1.00 (Ref)
Ex-smoker 6.3 ( 4.7- 8.5) 0.91 (0.63-1.30)
Current smoker 6.3 ( 4.3- 9.1) 0.90 (0.59-1.34)
ETS††
No 6.1 ( 5.3- 7.0) 1.00 (Ref) 1.00 (Ref)
Yes 8.6 ( 6.7-11.0) 1.45 (1.06-1.97)* 1.53 (1.09-2.16)}***
Chronic Bronchitis{{
No 6.5 (5.7-7.4) 1.00(Ref)
Yes 14.6 (9.8-21.2) 2.23 (1.38-3.59)
Rhinitis plus Sinusitis
No 6.4 ( 5.6- 7.3) 1.00 (Ref) 1.00 (Ref)
Yes 39.1 (24.9-55.4) 9.34 (4.75-18.35)** 13.93 (6.60-29.44)}}
Rhinitis without Sinusitis
No 4.6 ( 3.8- 5.5) 1.00 (Ref) 1.00 (Ref)
Yes 14.9 (12.6-17.6) 3.67 (2.79-4.82)** 3.87(2.90-5.18)}}
Sinusitis without Rhinitis
No 6.7 ( 5.9- 7.6) 1.00 (Ref) 1.00 (Ref)
Yes 8.7 ( 3.3-21.2) 1.33 (0.47-3.76)** 2.01 (0.64-6.34)
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Table 2 Prevalence of ‘Current asthma’ and logistic regression models with crude and adjusted Odds Ratio (OR)
(Continued)
Eczema
No 5.1 ( 4.3- 6.1) 1.00 (Ref) 1.00 (Ref)
Yes 11.5 ( 9.6-13.7) 2.41 (1.84-3.17)** 2.00 (1.50-2.66)}}
Food allergy
No 6.3 ( 5.5- 7.1) 1.00 (Ref) 1.00 (Ref)
Yes 15.7 (10.8-22.3) 2.79 (1.77-4.40)** 1.89 (1.15-3.10)}}*
Drug allergy
No 6.3 ( 5.5- 7.3) 1.00 (Ref) 1.00 (Ref)
Yes 11.9 ( 8.7-16.1) 2.00 (1.38-2.92)** 1.30 (0.86-1.95)
† ‘Pre-schoolers’ and <9 years were merged. {Socioeconomic status was categorized in high (A social class), medium (B and C social classes) and low (D social
class) based on occupation and school education of the person who contributes more for the household income. ††Environmental Tobacco Smoke. {{Chronic
bronchitis was defined as positive answer to questions “Did you have phlegm when coughing for at least 3 months in the last year?” and smoked more than 10
Packs-year and be at least 40 years old. *p < 0.25 **p < 0.001. } Final multiple logistic regression model included age, education level, ETS, , rhinitis plus sinusitis,
rhinitis without sinusitis, sinusitis without rhinitis, eczema, drug allergy and food allergy as risk factors for Current asthma. }*p = 0.006 }**p = 0.002 }***p = 0.015 }}
p< 0.001 }}*p = 0.012. Significant results in bold. OR – odds ratio.
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smoked more than 10 packs-year and is at least 40 years
old) didn’t change asthma prevalence estimates. After
these adjustments, the prevalence of asthma was lower in
elders without self-reported ‘heart disease’. This overesti-
mation of asthma symptoms in people with heart disease
may indicate a possible bias or confounding of the two
conditions, since heart disease is another cause of recur-
rent respiratory symptoms [1]. In spite of these limita-
tions, this is the only Portuguese study using a study-Table 3 Asthma comorbities for ‘Current asthma’ subjects (n =
Current asthma
Upper airways disease








Rhinitis+ /Sinusitis- 46.7 (
Sinusitis 6.4 (
Rhinitis - /Sinusitis+ 0.9 (
Both (Rhinitis+/Sinusitis+) 5.5 (
Chronic bronchitis 5.7 (
Non-respiratory allergic disease 55.4 (
Eczema/atopic dermatitis 44.3 (
Drug allergy 13.3 (
Food allergy 12.2 (
(−) indicates absence; (+) indicates presence; *p < 0.001.proved questionnaire on asthma that includes a large sam-
ple size from all municipalities and all age groups and
which estimates represent the prevalence in Portuguese
population.
An additional clinical evaluation including lung func-
tion tests would improve the accuracy of asthma classifi-
cation [3,4]. We designed and intend to proceed with a
clinical evaluation in a subsample of the participants that
will allow us to assess the effect of the survey misclassifi-
cation on asthma prevalence estimates.450) and for the total sample (n = 6003)
subjects, % (95%CI) Total sample, % (95%CI)
40.5-53.4)* 77.2 (75.7-78.7)
45.8-58.6)* 22.1 (20.7-23.6)
10.4-18.8)* 8.3 ( 7.4- 9.3)
8.6-16.7) 7.4 ( 6.6- 8.4)
1.0- 3.8) 0.9 ( 0.6- 1.2)
32.3-44.5)* 13.8 (12.6-15.1)
24.4-36.0) 11.1 (10.1-12.3)
5.7-12.0) 2.7 ( 2.2- 3.3)
40.4-53.2)* 21.2 (19.8-22.6)
4.3- 9.4)* 1.6 ( 1.2- 2.1)
0.3- 2.2) 0.7 ( 0.4- 1.0)
3.5- 8.5)* 1.0 ( 0.7- 1.3)
3.8- 8.5)* 2.7 ( 2.2- 3.2)
48.9-61.7)* 33.0 (31.4-34.7)
38.1-50.8)* 26.1 (24.6-27.7)
9.8-17.9)* 7.5 ( 6.7- 8.5)
8.3-17.6)* 5.3 ( 4.5- 6.1)
Figure 2 Current asthma prevalence in subgroups of adults by symptoms possible to affect the estimates. Symbols represent the
prevalence of ‘Current asthma’ in people: ♦ without chronic bronchitis; ▲who smoked ≤10 packs-year; ■ without self reported heart disease and
● all participants of the age group.
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GA2LEN definition of asthma included the symptoms
‘wheezing’; ‘waking with a feeling of tightness in the
chest’; ‘waking with breathlessness’ and ‘waking with
cough’. Using this definition our estimate was 7.8% (95%
CI 7.0-8.8). However, our definition of ‘Current asthma’
uses a more conservative combination of questions from
the GA2LEN survey. The selection of the questions
aimed to improve the specificity, namely by including
‘asthma attack’ and ‘waking with breathlessness’ [33-35]
(the less frequent nocturnal asthma-related symptom)






Waking with breathlessness 36.4
Waking with tightness in the chest 39.2
Waking with cough 55.7
Attack of asthma 46.9
Sputum for at least 3 months 45.4
Blocked nose 27.5
Sinus pressure 25.0
*p < 0.001.the chest’ or ‘waking with cough’. Our prevalence esti-
mate using this definition of ‘Current asthma’ (6.8%,
95%CI 6.0-7.7), was comparable to those found in
GA2LEN survey for Sweden (Gothenburg, 7.1%), Poland
(Krakow 7.1% and Lodz 6.0%), Netherlands (6.4%), Bel-
gium (7.6%) and Germany (Brandenburg 6.3%) but infer-
ior to Coimbra estimates (16.8%) [7].
A direct comparison of our prevalence estimates with
other studies previously done in Portugal is not straight-
forward given the differences in the methods and oper-
ational definitions used. Most of the asthma studies in
Portugal were done on school-attending children andths for ‘Current asthma’ subjects(n = 450) and total
a subjects, % (95%CI) Total sample, % (95%CI)
(85.8-91.6)* 18.1 (16.8-19.4)
(70.8-80.2)* 35.6 (33.9-37.3)
(30.7-42.6)* 6.8 ( 5.9- 7.7)
(33.3-45.4)* 11.9 (10.9-13.1)
(49.1-62.0)* 28.0 (26.4-29.7)




Table 5 Healthcare resources (Medication, diagnosis and hospitalization) for ‘Current asthma’ subjects(n = 450) and for
total sample(n =6003)
Current asthma subjects, % (95%CI) Total sample, % (95%CI)
Hospitalization because of asthma 25.6 (20.4-31.5) 2.4 ( 1.9- 2.9)
Lung function tests 57.4 (50.9-63.7) 23.6 (22.2-25.2)
Allergy tests
Any allergic test 65.7 (59.5-71.5) 25.2 (23.7-26.8)
Skin-prick test 55.2 (48.7-61.4) 17.9 (16.6-19.3)
Blood test 46.7 (40.3-53.1) 16.0 (14.7-17.4)
Asthma medication
Any asthma medication 60.1 (53.5-66.2) 5.0 ( 4.2- 5.8)
Inhaled Controller 35.2 (29.2-41.6) 2.9 ( 2.4- 3.6)
Only inhaled Reliever 21.6 (16.7-27.5) 1.5 ( 1.1- 1.9)
Nebulized aerosols 36.3 (30.2-42.9) 2.5 ( 2.0- 3.1)
Nebulized aerosols without controller† 17.6 (13.2-23.0) 1.2 ( 0.9- 1.6)
Antihistamine medication
Nasal spray 24.9 (19.8-30.7) 1.7 ( 1.3- 2.1)
Oral medication 45.3 (39.1-51.8) 3.1 ( 2.6- 3.7)
†Includes the participants using nebulized aerosols but not inhaled controller medication.
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prevalence of current asthma ranged from 3% to 8%
[8,10,13,19,21].
The ISAAC study in Portugal assessed the prevalence
of asthma in four cities. For children aged 6–7 years old
the global prevalence of asthma in last 12 months was
13% (in Lisboa, Portimão and Funchal); for teenagers
with 13–14 years old the global prevalence of current
asthma ranged between 9% in 1995 and 12% in 2002 (in
Lisboa, Porto, Portimão, Funchal)[5].
The ECRHS I included data were collected in two Por-
tuguese cities (Porto and Coimbra) [6]. A total of 3850
participants responded to the postal questionnaire, and
the estimated prevalence of asthma diagnosis was 4% in
Porto and 6% in Coimbra [6].
None of the previously published studies exclusively
on asthma conducted in Portugal can be confidently
generalized to the Portuguese population because of
methodological reasons (sampling methods, data collec-
tion or asthma definition used).
The only study done in the entire population addres-
sing both children and adults was the Portuguese Na-
tional Health Survey of 2005/2006. In this survey 3.5%
(368 184) reported having had asthma in last 12 months
[23], this is numerically inferior to the number of Portu-
guese ‘Current asthma’ estimated in the present study
(695 000). This could suggest an increase of asthma
prevalence commonly to other westernized countries
[36-39]. However, the comparison of the two studies
may be compromised due to the methodological differ-
ences stated above.Participant characteristics and asthma
Asthma prevalence was similar in both genders and in
all Portuguese regions, as observed in ONSA survey
[22]. The higher prevalence of asthma in older adult
population was also observed the Portuguese National
Health Survey [23] and ONSA [22].
Obesity has been associated with asthma [1,40,41]. Using
the Portuguese National Health Survey data, Moreira et al.
couldn’t show that higher BMI is an increased risk for
asthma [42]. Our results confirm this lack of association.
Additionally, lower educational level and SES has been
linked to an increased risk of asthma [1,43,44]. A study
in Portuguese adults, showed that the risk of asthma is
associated with lower monthly income and tended to be
higher in people with lower educational level [25]. In the
present study, educational level was associated with
asthma only after adjustment for the other variables.
SES was not associated with asthma.
‘Current asthma’ prevalence tended to be higher in non-
smokers or in those who smoked up to 10 packs-year, sug-
gesting either underreporting of asthma symptoms by par-
ticipants with tobacco-related diseases or that individuals
with respiratory symptoms are less likely to become smo-
kers or tend to quit smoking. Although this association is
controversial, similar result was observed in a case–con-
trol study based on ECHRS survey data: smokers showed
a 42% lower risk of asthma than did non-smokers (OR
0.58; 95% CI: 0.36 to 0.92) [45].
ETS may have an effect on asthma risk and on asthma
patients [1]. In the present study, exposure to ETS at
home is a significant risk factor for ‘Current asthma’.
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The association between asthma and rhinitis without si-
nusitis found in the present study (Crude OR 3.67, 95%
CI 2.79-4.82) is similar to other European studies [46]
supporting the concept of a frequent co-existence of
asthma and rhinitis in the same patient [1,27]. In fact,
rhinitis has been considered an important risk factor for
asthma development and severity [46]. An association
with sinusitis without rhinitis was also found (Crude OR
1.33, 95%CI 0.47-3.76), in agreement with the findings of
a recent European study [7]. This association was stron-
ger when both rhinitis and sinusitis were present, com-
parably to results from previous studies [7,47].
Healthcare resources
Almost half of the people with ‘Current asthma’ are not
receiving any asthma treatment, and a fifth is using only
rescue medication. Furthermore, about 40% of people
with wheeze denied having asthma. These facts seem to
suggest the need for improvement of diagnosis and
treatment of asthma as stated by the Global Alliance
against Chronic Respiratory Diseases [48].
Conclusion
In conclusion, 695,000 Portuguese have Current asthma,
with a prevalence of 6.8%, and more than one million
(10.5%) had Lifetime asthma. People who reported si-
nusitis and rhinitis had the strongest risk of having
Current asthma.
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